Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iron Chelation Therapy”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableLooking for participantsNCT04171635
What this trial is testing

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

Who this might be right for
MRI Scans
Weill Medical College of Cornell University 42
Testing effectiveness (Phase 2)Study completedNCT05392101
What this trial is testing

Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 12
Post-approval studies (Phase 4)Ended earlyNCT01818726
What this trial is testing

Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 15
Early research (Phase 1)Study completedNCT00004982
What this trial is testing

Combination Iron Chelation Therapy

Who this might be right for
Iron OverloadThalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT00379483
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 66
Not applicableUnknownNCT01996683
What this trial is testing

Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)

Who this might be right for
Beta-thalassemiaSerum FerritinIron Chelation Therapy
Ain Shams University 50
Large-scale testing (Phase 3)Ended earlyNCT00981370
What this trial is testing

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellTransfusion Hemosiderosis
Children's Hospital Los Angeles 1
Testing effectiveness (Phase 2)Study completedNCT00000588
What this trial is testing

Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone

Who this might be right for
Anemia (Iron-Loading)Beta-ThalassemiaHematologic Diseases+3 more
Case Western Reserve University 120
Large-scale testing (Phase 3)Study completedNCT04292314
What this trial is testing

Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia

Who this might be right for
Iron OverloadOxidative StressThalassemia Major
Beni-Suef University 350
Testing effectiveness (Phase 2)Study completedNCT04269889
What this trial is testing

Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

Who this might be right for
Anemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Study completedNCT00303329
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Who this might be right for
AnemiaHemosiderosis
Novartis Pharmaceuticals 184
Post-approval studies (Phase 4)Study completedNCT00800761
What this trial is testing

Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major

Who this might be right for
Iron OverloadCardiomyopathy
Ospedale Microcitemico
Not applicableUnknownNCT02474420
What this trial is testing

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Who this might be right for
Beta-ThalassemiaIron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC 60
Post-approval studies (Phase 4)UnknownNCT00103753
What this trial is testing

Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major

Who this might be right for
Beta-Thalassemia
Royal Brompton & Harefield NHS Foundation Trust 65
Large-scale testing (Phase 3)Study completedNCT00171210
What this trial is testing

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload in β-thalassemia
Novartis Pharmaceuticals 506
Testing effectiveness (Phase 2)Ended earlyNCT01604941
What this trial is testing

Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy

Who this might be right for
Iron Overload Due to Repeated Red Blood Cell Transfusions
Shire 32
Testing effectiveness (Phase 2)Study completedNCT01186419
What this trial is testing

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
Shire 51
Testing effectiveness (Phase 2)UnknownNCT00907283
What this trial is testing

Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)

Who this might be right for
Neurodegenerative DiseaseIron Overload
Ente Ospedaliero Ospedali Galliera 20
Not applicableUnknownNCT02833493
What this trial is testing

Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload

Who this might be right for
Aplastic AnemiaDysmyelopoietic SyndromesIron Overload
Peking Union Medical College Hospital 80
Not applicableStudy completedNCT05440487
What this trial is testing

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 489
Load More Results